Abstract
Coronary artery disease (CAD) is a significant global health problem, contributing to significant morbidity and mortality. Percutaneous coronary intervention (PCI) is an efficient therapy for treating CAD, but it carries the risk of iatrogenic endothelial injury, which contributes to vessel inflammation and induction of in-stent restenosis. Therefore, developing novel methods for enhancing re-endothelialization after PCI is highly needed. Endothelial progenitor cells (EPCs) can differentiate into mature endothelial cells, and cell therapy with EPC may offer a novel way for accelerating reendothelialization. In this review paper, we aimed to briefly describe EPCs and highlight their potential therapeutic roles in in-stent re-stenosis and endothelial injury.
Keywords: Coronary heart disease, endothelial cell, endothelial progenitor cell, endothelium injury, percutaneous coronary intervention, in-stent restenosis.
Current Stem Cell Research & Therapy
Title:Endothelial Progenitor Cells and In-stent Restenosis
Volume: 10 Issue: 4
Author(s): Bu-Yun Xu, Mei-Xiang Xiang and Jian-an Wang
Affiliation:
Keywords: Coronary heart disease, endothelial cell, endothelial progenitor cell, endothelium injury, percutaneous coronary intervention, in-stent restenosis.
Abstract: Coronary artery disease (CAD) is a significant global health problem, contributing to significant morbidity and mortality. Percutaneous coronary intervention (PCI) is an efficient therapy for treating CAD, but it carries the risk of iatrogenic endothelial injury, which contributes to vessel inflammation and induction of in-stent restenosis. Therefore, developing novel methods for enhancing re-endothelialization after PCI is highly needed. Endothelial progenitor cells (EPCs) can differentiate into mature endothelial cells, and cell therapy with EPC may offer a novel way for accelerating reendothelialization. In this review paper, we aimed to briefly describe EPCs and highlight their potential therapeutic roles in in-stent re-stenosis and endothelial injury.
Export Options
About this article
Cite this article as:
Xu Bu-Yun, Xiang Mei-Xiang and Wang Jian-an, Endothelial Progenitor Cells and In-stent Restenosis, Current Stem Cell Research & Therapy 2015; 10 (4) . https://dx.doi.org/10.2174/1574888X10666150204150430
DOI https://dx.doi.org/10.2174/1574888X10666150204150430 |
Print ISSN 1574-888X |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-3946 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Effect of Immunoglobulin Therapy on Blood Viscosity and potential concerns of Thromboembolism, Especially in Patients with Acute Kawasaki Disease
Recent Patents on Cardiovascular Drug Discovery Aspartic Proteinases in Disease: A Structural Perspective
Current Drug Targets Therapeutic Option of Plasmid-DNA Based Gene Transfer
Current Topics in Medicinal Chemistry COVID-19: A Great Mime or a Trigger Event of Autoimmune Manifestations?
Current Rheumatology Reviews Fibrinolytic Therapy in Acute Stroke
Current Cardiology Reviews Effect of Various Bulk Sweeteners on the Survivability of <i>Lactobacillus casei</i> 431 in Milk Chocolate: Rheological and Sensory Properties Analysis
Current Pharmaceutical Biotechnology microRNA-133: Expression, Function and Therapeutic Potential in Muscle Diseases and Cancer
Current Drug Targets The Chemistry of the Meliaceae and Ptaeroxylaceae of Southern and Eastern Africa and Madagascar
Current Organic Chemistry Pharmacokinetic Interactions Between Herbal Medicines and Prescribed Drugs: Focus on Drug Metabolic Enzymes and Transporters
Current Drug Metabolism Global Cardiovascular Risk Management in Primary Prevention
Current Vascular Pharmacology ESVS Guidelines: Section A - Prevention in Patients with Carotid Stenosis
Current Vascular Pharmacology Thiazolidinediones and Type 2 Diabetes: From Cellular Targets to Cardiovascular Benefit
Current Drug Targets The Emerging Role of Arginase in Endothelial Dysfunction in Diabetes
Current Vascular Pharmacology Crosstalk between Oxidative and Nitrosative Stress and Arterial Stiffness
Current Vascular Pharmacology Statins And Stroke
Current Medicinal Chemistry <i>Tylophora hirsuta</i> (Wall.) Extracts Ameliorate Diabetes Associated with Inflammation in Alloxan-induced Diabetic Rats
Endocrine, Metabolic & Immune Disorders - Drug Targets Preeclampsia and the Future Development of Cardiovascular Disease: A Review
Current Women`s Health Reviews Oral Health in Alzheimers Disease: A Review
Current Alzheimer Research Development of Tissue Engineered Vascular Grafts
Current Pharmaceutical Biotechnology Functional Recovery After Stroke: A Review of Current Developments in Stroke Rehabilitation Research
Reviews on Recent Clinical Trials